Skip to content
Disclosery

ORBIMED ADVISORS LLC: GPCR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on GPCR, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 2,209,400 GPCR shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,209,400 shares
    Change vs previous 13F +733,997 shares

    2.25% of the 13F portfolio, value $118,578,498.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,475,403 shares
    Change vs previous 13F +313,600 shares

    1.55% of the 13F portfolio, value $71,114,425.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,161,803 shares
    Change vs previous 13F +22,503 shares

    1.65% of the 13F portfolio, value $80,803,399.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,139,300 shares
    Change vs previous 13F -60,000 shares

    0.77% of the 13F portfolio, value $31,900,400.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,199,300 shares
    Change vs previous 13F +547,272 shares

    0.63% of the 13F portfolio, value $24,873,482.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 652,028 shares
    Change vs previous 13F 0 shares

    0.27% of the 13F portfolio, value $11,286,605.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 652,028 shares
    Change vs previous 13F +268,323 shares

    0.37% of the 13F portfolio, value $17,682,999.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 383,705 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $16,840,812.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).